# A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

Source: https://onco.cc/trials/nct07075328/  
OnCo record `nct07075328` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of an investigational treatment in non-Hodgkin lymphoma, run by Otsuka Medical Devices Co., Ltd. Japan, now recruiting.

## Summary

A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma is a phase 1/2 interventional study registered as NCT07075328 by Otsuka Medical Devices Co., Ltd. Japan, with 49 participants planned, started 2024-04-01 and due to reach its primary completion in 2028-02-28.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07075328
- Phase: 1/2
- Setting: A Phase I/II Study of OJP-001 for Recurrent or Relapsed Adult T-cell Leukemia/Lymphoma Patients With Peripheral Blood Tumor.
- Sponsor: Otsuka Medical Devices Co., Ltd. Japan
- Enrolled: 49

## Sources

- ClinicalTrials.gov NCT07075328: https://clinicaltrials.gov/study/NCT07075328

## Connected records

- cancers: [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)

---
JSON: https://onco.cc/api/v1/entities/nct07075328.json